French pharmaceutical giant Sanofi is investing $294 million to expand its global AI center of excellence in Toronto, Canada. This strategic move aims to fulfill the company’s mission of integrating artificial intelligence into every stage of the pharmaceutical value chain, from drug discovery to commercial operations.
Building a high-skilled talent pool Supported by a conditional grant from the Invest Ontario Fund, Sanofi plans to hire 50 new high-skilled employees in AI, machine learning, and data science by 2028.
-
Existing foundation: The Toronto hub already houses more than 150 roles specializing in cloud computing, data engineering, and bioinformatics.
-
Mission: The new team will help design and deploy AI tools to achieve Sanofi’s goal of halving the time from drug discovery to delivery of innovative treatments.
Breakthrough AI applications in medicine Sanofi has already demonstrated the power of AI through practical initiatives:
-
Digital Twins: Utilizing virtual patients to assess the safety and efficacy of drug candidates, which helped secure FDA pediatric approval for the enzyme replacement therapy Xenpozyme.
-
Knowledge Ecosystem: Partnering with BenchSci to create AI-driven knowledge graphs, enabling scientists to better understand disease biology using combined internal and public data.
The global Big Pharma AI race Sanofi’s expansion marks the latest development in the industry’s race to integrate AI technology:
-
Merck & Co: Inked a $1 billion partnership with Google Cloud for an agentic AI ecosystem.
-
Novo Nordisk: Teamed up with OpenAI to integrate AI into everyday operations.
-
Eli Lilly: Collaborated with Nvidia to build a supercomputer and an AI co-innovation lab.
-
Roche: Deployed thousands of Nvidia GPUs to create what it calls the industry’s largest “AI factory.”
The transition to new leadership under CEO Belén Garijo, who officially took over last week, is expected to further deepen Sanofi’s AI integration, leveraging her extensive background in electronics and high-tech industries.
Source: https://www.fiercepharma.com/pharma/sanofi-expands-ai-capabilities-investing-294m-scale-toronto-hub